VEGFR1 and VEGFR2 in lip carcinogenesis and its association with microvessel density
- 187 Downloads
The aim of the present study was to determine the role of vascular endothelial growth factor receptors (VEGFR1 and VEGFR2) in lip carcinogenesis, to investigate correlations between these markers with microvessel density (MVD) and clinicopathological aspects. Medical records from 27 cases of actinic cheilitis (AC) and 46 cases of lower lip squamous cell carcinoma (LLSCC) were analysed and submitted to immunohistochemistry. VEGFR1- and VEGFR2-immunostained sections were analysed based on percentage of positive epithelial and inflammatory cells, while CD31 was submitted to quantitative analysis to determine MVD. Different patterns of VGFR1 and VEGFR2 expression were observed between AC and LLSCC. VEGFR1 expression in epithelial and inflammatory cells and VEGFR2 expression in epithelial cells were higher in AC compared to LLSCC (p < 0.05). VEGFR1 expression in epithelial cells was higher in LLSCC compared to AC (p < 0.001). Expression of both receptors was not associated to MVD or clinicopathological aspects. A direct correlation was found between epithelial VEGFR1 and VEGFR2 expression (p = 0.02) and between VEGFR2 epithelial and inflammatory expression (p < 0.001). Our findings indicate that activation of VEGFR1 and VEGFR2 in epithelial and inflammatory cells appears to be an early event in lip carcinogenesis.
KeywordsOral squamous cell carcinoma Actinic cheilitis Potentially malignant disorders Vascular endothelial growth factor Angiogenesis
The authors are grateful to Flavia Rejane Giusti for technical support.
Conflicts of interest
This study was supported by the Postgraduate Research Group of the Porto Alegre University Hospital (GPPG/FIPE: 14-0042). Luise Meurer and Manoela Domingues Martins are research fellows funded by the Brazilian National Council for Scientific and Technological Development (CNPq).
- 3.Corso FM, Wild C, Gouveia LO, Ribas MO. Actinic cheilitis: prevalence in dental clinics from PUCPR, Curitiba, Brazil. Clin Pesq Odontol. 2006;2:227–81.Google Scholar
- 13.Margaritescu C, Pirici D, Simionescu C, Mogoanta L, Raica M, Stinga A, et al. VEGF and VEGFRs expression in oral squamous cell carcinoma. Rom J Morphol Embryol Rev Roum Morphol Embryol. 2009;50(4):527–48.Google Scholar
- 15.Reinmuth N, Liu W, Jung YD, Ahmad SA, Shaheen RM, Fan F, et al. Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J Off Publ Fed Am Soc Exp Biol. 2001;15(7):1239–41.Google Scholar
- 16.Dias S, Hattori K, Heissig B, Zhu Z, Wu Y, Witte L, et al. Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias. Proc Natl Acad Sci U S A. 2001;98(19):10857–62.CrossRefPubMedPubMedCentralGoogle Scholar
- 19.Stinga AC, Margaritescu O, Stinga AS, Pirici D, Ciurea R, Bunget A, et al. VEGFR1 and VEGFR2 immunohistochemical expression in oral squamous cell carcinoma: a morphometric study. Rom J Morphol Embryol Rev Roum Morphol Embryol. 2011;52(4):1269–75.Google Scholar
- 26.Kyzas PA, Stefanou D, Batistatou A, Agnantis NJ. Potential autocrine function of vascular endothelial growth factor in head and neck cancer via vascular endothelial growth factor receptor-2. Mod Pathol Off J U S Can Acad Pathol Inc. 2005;18(4):485–94.Google Scholar
- 29.Ciurea R, Margaritescu C, Simionescu C, Stepan A, Ciurea M. VEGF and his R1 and R2 receptors expression in mast cells of oral squamous cells carcinomas and their involvement in tumoral angiogenesis. Rom J Morphol Embryol Rev Roum Morphol Embryol. 2011;52(4):1227–32.Google Scholar
- 30.Thompson L. Health Organization classification of tumours. Pathology and genetics of tumours of the head and neck. Ear Nose Throat J. 2005;85(2):74.Google Scholar
- 32.Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, et al. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness. Histopathology. 2012;61(3):350–64.CrossRefPubMedGoogle Scholar
- 39.Carlile J, Harada K, Baillie R, Macluskey M, Chisholm DM, Ogden GR, et al. Vascular endothelial growth factor (VEGF) expression in oral tissues: possible relevance to angiogenesis, tumour progression and field cancerisation. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol. 2001;30(8):449–57.Google Scholar